Results 191 to 200 of about 5,282,959 (357)
Epidemiologic and Symptomatologic Observations on the Gastric Cancer Patients
Hideo Uehara +10 more
openalex +2 more sources
Cadmium, a carcinogenic heavy metal, drives breast cancer progression via metabolic reprogramming and autophagic flux disruption. Multi‐omics revealed cadmium‐induced 5'‐methylthioadenosine depletion activates DOT1L‐mediated H3K79me1 at PAK2 promoter, upregulating PAK2 to block autophagy and driving malignancy. Clinically, 5'‐methylthioadenosine levels
Jingdian Li +24 more
wiley +1 more source
Deciphering the viral landscape in gastric cancer: comprehensive characterization and identification of the gastric cancer virome. [PDF]
Xiang D +17 more
europepmc +1 more source
Differences of gastric cancers between the greater and the lesser curvature
Satoru Mizuno
openalex +2 more sources
Compared with EBV‐negative epithelial cancer cells, EBV‐associated epithelial cancer cells exhibit enhanced secretion of chemokines, including CXCL10 and CCL5, to attract neutrophils. Via the CXCL10‐CXCR3 axis‐mediated positive feedback loop, neutrophils within EBV‐associated epithelial cancer cells are induced to form abundant NETs, which facilitate ...
Dijun Ouyang +24 more
wiley +1 more source
Current debate in gastric cancer surgery: Omentectomy? [PDF]
Ilhan E, Yildirim M.
europepmc +1 more source
STUDIES ON METASTASIS OF GASTRIC CANCER (THE FIRST REPORT)
Dennosuke Jinnai +10 more
openalex +2 more sources
Advanced Microfluidics for Single Cell‐Based Cancer Research
Cutting‐edge microfluidic platforms are transforming single‐cell cancer research. This review highlights advanced technologies, from droplet microfluidics to tumour‐chips, that enable functional and spatial single‐cell analyses. By integrating biosensing, immune components, and patient‐derived materials, these systems offer new insights into tumour ...
Adriana Carneiro +10 more
wiley +1 more source
Mechanisms, advances, and challenges of immunotherapy in gastric cancer. [PDF]
Wang Z, Wang T.
europepmc +1 more source
PAD1 is upregulated within the CD133+ subset or cisplatin‐resistant ovarian cancer cells, which is positively associated with the upregulation of stemness‐related markers and maintenance of stemness in OCSLCs. Mechanistically, PAD1‐catalyzed AKT2 citrullination at R202 facilitates AKT2 phosphorylation, promoting CEBPβ expression and its binding to the ...
Teng Xue +10 more
wiley +1 more source

